MDCXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as MDCXW
Medicus Pharma Ltd.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$2.65−0.60 (-18.31%)
Close on Oct 19, 2026
- Market cap
- $146.17M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$115.35 (−97.75%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $146.17M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$56.66M
- EPS, diluted
- -$2.45
- Book value per share
- -$0.03
- Diluted shares
- 55M
Four years at a glance
Fiscal years 2022 to 2025 and trailing twelve months, USD
Operating income
-$27.87M
Net income
-$56.66M
EPS, diluted
-$2.45
Reported periodTrailing twelve months